Armata Pharmaceuticals (ARMP) Return on Sales (2013 - 2020)

Armata Pharmaceuticals (ARMP) has 6 years of Return on Sales data on file, last reported at 1.77% in Q2 2020.

• For the quarter ending Q2 2020, Return on Sales changed N/A year-over-year to 1.77%; the trailing twelve-month figure through Jun 2020 stood at 0.32% (changed N/A YoY), and the FY2017 full-year result was 0.49%, down 27.0% from the prior year.
• Return on Sales eased to 1.77% in Q2 2020, from 2.43% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 2.43% in Q4 2017 to a low of 2.31% in Q2 2017.
• A 3-year average of 0.37% and a median of 0.45% in 2016 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales soared 158 bps in 2016 and slumped 193 bps in 2017, its largest moves.
• Tracing ARMP's Return on Sales over 3 years: stood at 1.35% in 2016, then surged by 79 bps to 2.43% in 2017, then slumped by 173 bps to 1.77% in 2020.
• Business Quant data shows ARMP's Return on Sales at 1.77% in Q2 2020, 2.43% in Q4 2017, and 0.2% in Q3 2017.